✨ Your Portfolio is fetched and updated from zerodha.
Nano Agriculture

Shree Ganesh Bio-Tech (India) Ltd.

SHREEGANES

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹30 Cr.
P/E
63.51

Shree Ganesh Bio-Tech (India) Ltd.

  • Shree Ganesh BioTech
  • Shree Oswal Seeds
  • JK Agri Genetics

FAQs on Shree Ganesh Bio-Tech (India) Ltd. Shareprice

Shree Ganesh BioTech has given lower returns compared to its competitors.
Shree Ganesh BioTech has grown at ~-23.54% over the last 3yrs while peers have grown at a median rate of 0.48%

Shree Ganesh BioTech is not expensive.
Latest PE of Shree Ganesh BioTech is 63.51, while 3 year average PE is 125.
Also latest EV/EBITDA of Shree Ganesh BioTech is 0.0 while 3yr average is 453.

View FAQ's On Business

Growth Table

  • Shree Ganesh Bio-Tech (India) Ltd.
  • Shree Oswal Seeds
  • JK Agri Genetics

Balance Sheet

  • Shree Ganesh Bio-Tech (India) Ltd.
  • Shree Oswal Seeds
  • JK Agri Genetics

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Shree Ganesh Bio-Tech (India) Ltd.
  • Shree Oswal Seeds
  • JK Agri Genetics

Cash Flow

  • Shree Ganesh Bio-Tech (India) Ltd.
  • Shree Oswal Seeds
  • JK Agri Genetics

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Shree Ganesh Bio-Tech (India) Ltd.
  • Shree Oswal Seeds
  • JK Agri Genetics

Quarterly Results

  • Shree Ganesh Bio-Tech (India) Ltd.
  • Shree Oswal Seeds
  • JK Agri Genetics

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Shree Ganesh Bio-Tech (India) Ltd. Financials

Balance sheet of Shree Ganesh BioTech is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Shree Ganesh BioTech is increasing.
Latest net debt of Shree Ganesh BioTech is -₹0.02 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹0.85 Crs.

No, profit is decreasing.
The profit of Shree Ganesh BioTech is ₹0.28 Crs for Mar 2025, ₹0.62 Crs for Mar 2024 and ₹2.04 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Shree Ganesh BioTech latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments, Capital Work in Progress, Inventory, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech